Daewon Pharmaceutical Co., Ltd. (KRX:003220)

South Korea flag South Korea · Delayed Price · Currency is KRW
10,720
-90 (-0.83%)
Apr 30, 2026, 3:30 PM KST
Market Cap231.70B -19.3%
Revenue (ttm)605.43B +1.2%
Net Income-1.38B
EPS-87.38
Shares Out21.43M
PE Ration/a
Forward PE16.21
Dividend250.00 (2.30%)
Ex-Dividend DateDec 29, 2025
Volume16,258
Average Volume29,561
Open10,830
Previous Close10,810
Day's Range10,660 - 10,830
52-Week Range9,670 - 14,700
Beta0.26
RSI51.93
Earnings DateMay 15, 2026

About Daewon Pharmaceutical

Daewon Pharmaceutical Co., Ltd., a pharmaceutical company, manufactures and sells medicines and medical supplies in South Korea. It offers various medicines for circulatory, respiratory, antibiotic, chemotherapy, and psychoneurosis use. The company’s principal products include Oramin-F Soft Cap, a multivitamin product; Pelubi Tablet, a NSAID product for pain relief; Freefol-MCT Inj., a microemulsion propofol for the anti-exogenous infectious bacteria; Megex-I Susp, a medicine that supplements subalimentation of cancer patients; Trigel Susp, a t... [Read more]

Sector Healthcare
Founded 1958
Employees 1,283
Stock Exchange Korea Stock Exchange
Ticker Symbol 003220
Full Company Profile

Financial Performance

Financial Statements